/
Phase I Trials:   Statistical Design Considerations Phase I Trials:   Statistical Design Considerations

Phase I Trials: Statistical Design Considerations - PowerPoint Presentation

marina-yarberry
marina-yarberry . @marina-yarberry
Follow
399 views
Uploaded On 2018-03-18

Phase I Trials: Statistical Design Considerations - PPT Presentation

Hong Li Acknowledgement some slides from Rick Chappell Univ of Wisc Historically DOSE FINDING study Determine maximal tolerated dose MTD Recommend dose for Phase II clinical trials ID: 655948

toxicity dose phase patients dose toxicity patients phase toxicities design crm dlt level treated patient mci mtd based model

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Phase I Trials: Statistical Design Con..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript